Botox is an effective, FDA-approved treatment for chronic migraines, cutting headache frequency in half for roughly 65% of patients after three rounds of treatment. It’s specifically approved for adults who experience 15 or more headache days per month, with headaches lasting four hours or longer. If your migraines are less frequent than that (episodic migraines), Botox isn’t the standard recommendation, and insurance likely won’t cover it.
Who Qualifies for Botox Treatment
The FDA approval draws a clear line: chronic migraine means 15 or more headache days per month, with each episode lasting at least four hours. That threshold matters for both medical and practical reasons. Clinical trials tested Botox specifically on this population, so the evidence supporting its effectiveness applies to people in that category. If you get migraines 10 days a month, even severe ones, you fall into the episodic migraine category, and other preventive treatments are typically tried first.
Most insurers, including Medicare, require that you’ve already tried and failed other preventive medications before they’ll approve Botox. This prior authorization step can add time before you start treatment, but it’s a standard part of the process.
How Well It Actually Works
The landmark clinical trials (known as the PREEMPT studies) tracked 688 patients receiving Botox for chronic migraine. After the first treatment cycle, 49.3% of patients saw their headache days drop by at least half. That’s a meaningful result on its own, but the picture improves with continued treatment. An additional 11.3% responded after the second cycle, and another 10.3% after the third. Altogether, about 65% of patients achieve at least a 50% reduction in monthly headache days after three rounds of treatment.
Those results also held up over time. A study following patients who responded to the initial three courses found the benefits sustained over three years of continued treatment. For the subset of patients who do respond, Botox provides reliable, long-term migraine prevention rather than a temporary fix.
The flip side: roughly one in three patients doesn’t get meaningful relief even after three cycles. Botox isn’t a guarantee, and there’s no reliable way to predict beforehand whether you’ll be a responder.
What the Treatment Looks Like
Each session takes about 15 minutes. You’ll receive 31 small injections spread across seven muscle groups in your head, neck, and shoulders. The specific areas include your forehead, temples, the back of your head, your neck muscles, and the trapezius muscles along your upper back. Each injection delivers a small, fixed dose for a total of 155 units per session.
The injections use very fine needles. Most people describe the sensation as a pinch or brief stinging rather than significant pain. You can go back to normal activities the same day, though some providers suggest avoiding heavy exercise for 24 hours.
Treatments are repeated every 12 weeks. The effects typically last 10 to 12 weeks, so some people notice their migraines creeping back in the week or two before their next appointment. You should start feeling initial results within one to two weeks after your first session, though it can take multiple treatment cycles (meaning several months) to see the full benefit.
Side Effects
Botox for migraines has a favorable safety profile, especially compared to daily oral medications that can cause fatigue, weight changes, or cognitive fog. In a long-term study tracking 579 patients over up to 11 years, the overall rate of side effects was low: about 3 events per 100 person-years of treatment.
When side effects did occur, the vast majority (87.5%) were mild neck pain at the injection sites. The remaining 12.5% involved temporary eyelid drooping, which resolved on its own. Serious complications are rare. Because the Botox stays localized to the injection area, it doesn’t produce the systemic side effects that many oral migraine preventives do.
What It Costs With and Without Insurance
The sticker price for Botox is high if you’re paying entirely out of pocket, but most patients don’t. For people with commercial insurance, the average out-of-pocket cost comes to about $26 per month, including both the medication and the procedure itself. Medicare patients pay even less, averaging around $16 per month, though Medicare requires documentation that other treatments haven’t worked.
AbbVie, the company that makes Botox, runs a savings program for commercially insured patients that covers up to $1,300 in out-of-pocket costs for the first treatment and up to $1,000 for each treatment after that, with a yearly cap of $4,000. For uninsured or underinsured patients with household income at or below 300% of the federal poverty level, a separate patient assistance program (myAbbVie Assist) can help cover the cost entirely.
If your insurance denies coverage, the Patient Advocate Foundation offers resources specifically for navigating migraine treatment denials and appeals at patientadvocate.org/migrainematters.
How It Compares to Other Migraine Preventives
Botox occupies a specific niche in migraine treatment. It’s not typically a first-line option for people who’ve never tried preventive medication. Most treatment plans start with oral preventives, and Botox enters the picture when those aren’t effective or cause intolerable side effects. For people who qualify, though, it offers some distinct advantages: injections every 12 weeks instead of daily pills, minimal systemic side effects, and sustained effectiveness that doesn’t diminish over years of use.
Newer injectable treatments that target a protein called CGRP (involved in migraine pain signaling) are now available as alternatives in a similar space. These are given monthly or quarterly and work through a different mechanism. Some patients who don’t respond to Botox do well on CGRP-targeting treatments, and vice versa. Your treatment history, insurance coverage, and how your body responds will determine which option makes the most sense.
Setting Realistic Expectations
The most important thing to understand about Botox for migraines is the timeline. Unlike pain relievers that work within hours, Botox is a preventive treatment that builds over months. You may notice modest improvement after the first session, but many patients don’t hit their stride until the second or third cycle, meaning 24 to 36 weeks from the first injection. Giving up after one round that didn’t seem to help means potentially missing out on a treatment that would have worked with more time.
For the majority of patients who do respond, the payoff is significant: going from 15 or more headache days a month to seven or fewer changes daily life in ways that go well beyond pain reduction. It affects work capacity, sleep, relationships, and the constant anxiety of wondering when the next migraine will hit. That sustained relief, maintained over years with quarterly appointments, is what makes Botox one of the most impactful options available for chronic migraine.